These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26862372)

  • 1. Role of diabetes in heart rhythm disorders.
    Koektuerk B; Aksoy M; Horlitz M; Bozdag-Turan I; Turan RG
    World J Diabetes; 2016 Feb; 7(3):45-9. PubMed ID: 26862372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].
    Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M
    Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical characteristics and risk of stroke and death within 1 year of patients with nonvalvular atrial fibrillation combined with diabetes mellitus].
    Wu S; Yang YM; Zhu J; Huang B; Wang J; Wan HB; Zhang H; Shao XH
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2044-8. PubMed ID: 27468614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    Yonsei Med J; 2015 Jan; 56(1):62-71. PubMed ID: 25510748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Vasiljevic ZM; Vujisic-Tesic BD; Marinkovic JM; Polovina MM; Stepanovic JM; Stankovic GR; Ostojic MC; Lip GYH
    Chest; 2011 Oct; 140(4):902-910. PubMed ID: 21436252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches in the treatment of atrial fibrillation.
    Tamargo J; Caballero R; Delpón E
    Curr Med Chem; 2004 Jan; 11(1):13-28. PubMed ID: 14754423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus and atrial fibrillation: evidence of a pathophysiological, clinical and epidemiological association beyond the thromboembolic risk].
    Proietti R; Russo V; Wu MA; Maggioni AP; Marfella R
    G Ital Cardiol (Rome); 2017 Mar; 18(3):199-207. PubMed ID: 28398378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the loire valley atrial fibrillation project.
    Lip GYH; Clementy N; Pierre B; Boyer M; Fauchier L
    Chest; 2015 Apr; 147(4):1103-1110. PubMed ID: 25412290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.
    Kannel WB; Wolf PA; Benjamin EJ; Levy D
    Am J Cardiol; 1998 Oct; 82(8A):2N-9N. PubMed ID: 9809895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management.
    Pouwels S; Topal B; Knook MT; Celik A; Sundbom M; Ribeiro R; Parmar C; Ugale S
    Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):209-223. PubMed ID: 30757925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Overview of Obesity and Diabetes Mellitus as Risk Factors for Atrial Fibrillation and Sudden Cardiac Death.
    Homan EA; Reyes MV; Hickey KT; Morrow JP
    Front Physiol; 2018; 9():1847. PubMed ID: 30666210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links.
    Goudis CA; Korantzopoulos P; Ntalas IV; Kallergis EM; Ketikoglou DG
    J Cardiol; 2015 Nov; 66(5):361-9. PubMed ID: 25959929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus.
    Moss AS; Dimitropoulos G; Connolly DL; Lip GYH
    Expert Opin Pharmacother; 2017 Aug; 18(11):1101-1114. PubMed ID: 28669216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study.
    Romanov A; Martinek M; Pürerfellner H; Chen S; De Melis M; Grazhdankin I; Ponomarev D; Losik D; Strelnikov A; Shabanov V; Karaskov A; Pokushalov E
    Europace; 2018 Feb; 20(2):263-270. PubMed ID: 28069838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction.
    Stamboul K; Fauchier L; Gudjoncik A; Buffet P; Garnier F; Lorgis L; Beer JC; Touzery C; Cottin Y
    Arch Cardiovasc Dis; 2015 Nov; 108(11):598-605. PubMed ID: 26525569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry.
    Bogossian H; Frommeyer G; Brachmann J; Lewalter T; Hoffmann E; Kuck KH; Andresen D; Willems S; Spitzer SG; Deneke T; Thomas D; Hochadel M; Senges J; Eckardt L; Lemke B
    Int J Cardiol; 2016 Jul; 214():25-30. PubMed ID: 27057967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?
    Matta M; Saglietto A; De Salvo P; Bissolino A; Ballatore A; Anselmino M
    Herz; 2019 May; 44(3):218-222. PubMed ID: 30847508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).
    Bansilal S; Bloomgarden Z; Halperin JL; Hellkamp AS; Lokhnygina Y; Patel MR; Becker RC; Breithardt G; Hacke W; Hankey GJ; Nessel CC; Singer DE; Berkowitz SD; Piccini JP; Mahaffey KW; Fox KA;
    Am Heart J; 2015 Oct; 170(4):675-682.e8. PubMed ID: 26386791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.